EXPLORATORY STUDY OF THE MYHEARTSENTINEL SYSTEM, A CARDIAMETRICS MEDICAL DEVICE
Recruiting
N/A
Interventional Study
Heart Failure
Telemonitoring
Right Heart Catheterisation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 70 (estimated)
- Sponsor
- University Hospital, Caen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Background:
Chronic heart failure represents a major public health challenge, affecting approximately 64 million people worldwide and generating high costs in terms of mortality, frequent hospitalizations, and medical expenses. In France, this disease is expected to cause nearly 70,000 deaths and 181,000 hospital admissions in 2022. Current management, based on periodic consultations, fails to ef…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged between 18 and 90 years
* Affiliated with the social security system.
* Patients who have been informed of the study and have signed informed consent.
* Patients with heart failure and one of the following two criteria:
* Hospitalized for hemodynamic assessmen…
Contacts
No contact information available.